Zepbound®
- FDA-approved for chronic weight management (2023)
- Published trial results: SURMOUNT-1, NEJM
- Manufactured by Eli Lilly in fixed pen doses
- FDA-reviewed for safety, effectiveness, and quality
- At PinwellRx: $1,086/mo, never discounted
Compounded tirzepatide
- Prepared to order by licensed U.S. 503A pharmacies
- Not FDA-approved; not reviewed by FDA before marketing
- Trial results for Zepbound do not apply to it
- Dosing set individually by the prescribing clinician
- At PinwellRx: $339/mo when prescribed
Does compounded tirzepatide work as well as Zepbound?
Honestly: no one can say. The SURMOUNT-1 results reported in NEJM - the numbers you see in headlines - were produced with Zepbound®, under trial conditions, with FDA-reviewed manufacturing. No equivalent published trials exist for compounded tirzepatide, so its results cannot be claimed to match. What a clinician can say is whether tirzepatide as a molecule is appropriate for you, and which form fits your health history and budget.
Is compounded tirzepatide legal?
FDA compounding guidance permits licensed pharmacies to prepare compounded medications for individual patients when prescribed by a licensed clinician. FDA states that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing. PinwellRx works only with licensed U.S. pharmacies, and every prescription requires a clinician's independent decision.
Which one should I choose?
That is a clinical decision, not a shopping decision. Some patients want the FDA-approved product and its published evidence; others need a price that fits their life. At PinwellRx you complete one intake, a licensed clinician reviews it, and you see the price of any option before you pay. Brand-name medications are never discounted and never substituted without your knowledge.
Ready to see which fits you?
A licensed clinician reviews every intake. You’ll see your price before you pay, and nothing ships unless a clinician prescribes it.
- FDA prescribing information - Zepbound (tirzepatide)
- NEJM - SURMOUNT-1 trial of tirzepatide (Zepbound)
- FDA - Human Drug Compounding
- Drugs@FDA - approved drug products